HomeTrialNCT06275724
🔬NCT06275724ACTIVE NOT RECRUITING

Specified Drug-use Survey of Leqvio for s.c. Injection.

Study Summary

The objective of this study is to evaluate the long-term safety of Leqvio in patients with familial hypercholesterolaemia or hypercholesterolaemia in post-marketing clinical practice

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment585 participants
Primary Completion
Lead SponsorNovartis Pharmaceuticals
Data Retrieved2026-04-11 02:55:49.151482+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.